12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·03/19/2026 17:05:45
Listen to the news
Gainers
Serina Therapeutics (AMEX:SER) shares moved upwards by 94.5% to $2.49 during Thursday's regular session. The company's market cap stands at $13.8 million.
Acurx Pharmaceuticals (NASDAQ:ACXP) stock rose 30.13% to $6.78. The market value of their outstanding shares is at $13.2 million. As per the news, the Q4 earnings report came out 4 days ago.
Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares moved upwards by 15.51% to $2.68. The market value of their outstanding shares is at $4.2 million. The company's, Q4 earnings came out 4 days ago.
Aldeyra Therapeutics (NASDAQ:ALDX) stock rose 15.14% to $1.64. The company's market cap stands at $85.4 million.
Tonix Pharmaceuticals (NASDAQ:TNXP) stock increased by 12.86% to $16.02. The market value of their outstanding shares is at $190.2 million.
CytomX Therapeutics (NASDAQ:CTMX) shares increased by 11.36% to $4.9. The company's market cap stands at $745.5 million. The company's, Q4 earnings came out 3 days ago.
Losers
Reviva Pharmaceuticals (NASDAQ:RVPH) shares fell 55.0% to $0.84 during Thursday's regular session. The company's market cap stands at $10.9 million.
Bio Green Med Solution (NASDAQ:BGMSP) stock declined by 32.53% to $1.95.
Processa Pharmaceuticals (NASDAQ:PCSA) stock decreased by 28.17% to $2.27. The market value of their outstanding shares is at $7.1 million.
Profusa (NASDAQ:PFSA) shares declined by 23.52% to $0.58. The company's market cap stands at $1.0 million.
Agilon Health (NYSE:AGL) stock declined by 21.63% to $0.46. The market value of their outstanding shares is at $244.8 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.